New Capital Management’s AbbVie ABBV Stock Holding History

New Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$821K	Buy	3,263 +8	+0.2%	+$1.72K	0.19%	36
2026 Q1	$708K	Buy	3,255 +11	+0.3%	+$2.44K	0.17%	38
2025 Q4	$741K	Sell	3,244 -10	-0.3%	-$2.28K	0.19%	35
2025 Q3	$753K	Buy	3,254 +180	+6%	+$36.7K	0.2%	33
2025 Q2	$571K	Buy	3,074 +74	+2%	+$13.8K	0.16%	36
2025 Q1	$629K	Hold	3,000	–	–	0.18%	29
2024 Q4	$533K	Hold	3,000	–	–	0.16%	34
2024 Q3	$592K	Hold	3,000	–	–	0.17%	29
2024 Q2	$515K	Hold	3,000	–	–	0.16%	36
2024 Q1	$546K	Hold	3,000	–	–	0.16%	36
2023 Q4	$465K	Sell	3,000 -1,500	-33%	-$219K	0.15%	38
2023 Q3	$671K	Buy	+4,500	New	+$661K	0.23%	33
2023 Q1	$717K	Hold	4,500	–	–	0.27%	31
2022 Q4	$727K	Hold	4,500	–	–	0.31%	29
2022 Q3	$604K	Hold	4,500	–	–	0.33%	26
2022 Q2	$684K	Sell	4,500 -228	-5%	-$34.8K	0.38%	26
2022 Q1	$766K	Buy	+4,728	New	+$687K	0.55%	25
2018 Q1	–	Sell	-151	Closed	-$15K	–	151
2017 Q4	$15K	Hold	151	–	–	0.02%	115
2017 Q3	$13K	Hold	151	–	–	0.02%	123
2017 Q2	$10K	Hold	151	–	–	0.02%	131
2017 Q1	$10K	Hold	151	–	–	0.02%	131
2016 Q4	$9K	Buy	+151	New	+$9.22K	0.01%	127

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

New Capital Management's ABBV Position: Q2 2026 in Review

New Capital Management increased its AbbVie (ABBV) stake by 0.25% in Q2 2026, buying an estimated $1.72K and bringing the position to 3,263 shares worth $821K. The position accounts for 0.19% of the portfolio, ranked #36.

New Capital Management first reported a position in ABBV in Q4 2016 and has held it in 22 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

New Capital Management held 3,263 shares of AbbVie worth $821K as of Q2 2026.
New Capital Management bought 8 AbbVie shares in Q2 2026, an estimated $1.72K.
AbbVie made up 0.19% of New Capital Management's portfolio in Q2 2026, its #36 holding.
New Capital Management first reported a position in AbbVie in Q4 2016 and has held it in 22 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on New Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.